Endothel Pharma ApS — Credit Rating and Financial Key Figures

CVR number: 37988936
Frederiksgade 19, 1265 København K
sisse.ostrowski@gmail.com

Income statement (kDKK)

2020
2021
2022
2023
2024
Fiscal period length1212121212
Net sales
Gross profit-12.62-25.13-47.87-57.14-42.29
EBIT-12.62-25.13-47.87-57.14-42.29
Other financial expenses-16.31-21.48-28.39-33.86-39.33
Pre-tax profit-28.93-46.61-76.25-91.00-81.62
Net earnings-28.93-46.61-76.25-91.00-81.62

Assets (kDKK)

2020
2021
2022
2023
2024
Development expenditure340.22500.83503.08531.70531.70
Intangible assets total340.22500.83503.08531.70531.70
Tangible assets total
Investments total
Long term receivables total
Inventories total
Current other receivables0.8241.380.942.482.56
Short term receivables total0.8241.380.942.482.56
Cash and bank deposits27.460.4950.6524.5641.13
Cash and cash equivalents27.460.4950.6524.5641.13
Balance sheet total (assets)368.50542.71554.67558.74575.39

Equity and liabilities (kDKK)

2020
2021
2022
2023
2024
Share capital75.0075.0075.0075.0075.00
Other reserves340.22500.83503.08531.70531.70
Retained earnings- 466.75- 656.29- 705.15- 810.02- 901.02
Profit of the financial year-28.93-46.61-76.25-91.00-81.62
Shareholders equity total-80.46- 127.07- 203.32- 294.32- 375.94
Non-current liabilities total
Current trade creditors13.2313.4213.7915.9616.39
Other non-interest bearing current liabilities435.72656.36744.20837.11934.94
Current liabilities total448.96669.78757.99853.06951.33
Balance sheet total (liabilities)368.50542.71554.67558.74575.39
Try the full version of our system for free
Bankruptcy risk visualization example

... and more!

No registration needed.